CAvent-Ventilation During Advanced Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest- an Observational Study (CAvent)

March 31, 2026 updated by: Sten Rubertsson, Uppsala University

The aim of this observational study is to investigate how ventilations is given during cardiopulmonary resuscitation (CPR) given by advanced life support providers (ALS). A portable device capable of detailed measurments of ventilation will be used when ventilating patients suffering cardiac arrest.

The main objective of the study is to describe the ventilatiosn given in terms of volume, frequency and pressure, both overall and during different CPR modes and when using different methods to handle the patients airway.

Study Overview

Detailed Description

The aim with this observational multicenter study is to measure and describe manual ventilation during cardiopulmonary resuscitation in the advance life support setting.

Primary endpoint is the ventilation quality measured as ventilation frequency, tidal volume, minute ventilation peak inspiratory pressure and exhaled CO2.

This will be studied in both asycnhronous ventilations, meaning ventilations that are given during ongoing chest compressions and syncrhonous ventilations, meaning ventilations given during a pause of the chest compressions, in a 30:2 repeatign pattern. Aditionally, airway modalities such as bag-valve-masks, Supraglottic airway devices and endotracheal tubes will be studied.

The inclusion of patients will be performed at five sites, The Uppsala emergency medical services, Uppsala, Sweden, Capio AB akutläkarbilar (rapid response cars), Stockholm Sweden, Falun County hospital, Falun, Sweden, EMS Amsterdam post West, Amsterdam, The Netherlands and Lifeliner 1 HEMS, Amsterdam, The Netherlands Eligible for inclusion are patients over 18 years old suffering cardiac arrest in the areas served by the including emergency medical systems and in-hospital emergency team.

The goal is to include at least 200 patients.

Study Type

Observational

Enrollment (Actual)

241

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amsterdam, Netherlands
        • Amsterdam UMC
    • Utrecht
      • Amersfoort, Utrecht, Netherlands
        • Regionale Ambulance Voorziening Utrecht, Netherlands
      • Falun, Sweden
        • Falun county hospital
      • Stockholm, Sweden
        • Capio AB Rapid Response Cars
      • Uppsala, Sweden, 75185
        • Uppsala University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients suffering sudden cardic arrest treated with CPR by ALS-providers in Uppsala, Amsterdam, Stockholm and Falun county hospital.

Description

Inclusion Criteria:

Out-of-hospital cardiac arrest (OHCA) treated with CPR performed by the EMS personnel

Exclusion Criteria:

  • Patient age < 18 years
  • Known pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient recieving asycnhronous ventilations
Fluxmed GrH portable pneumotachograph is used to measure the given ventilation. It is placed on the chosen airway adjunct and passively measures ventilation parameters such as volumes, and flow.
Patient recieving synchronous ventilations
Fluxmed GrH portable pneumotachograph is used to measure the given ventilation. It is placed on the chosen airway adjunct and passively measures ventilation parameters such as volumes, and flow.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilation frequency
Time Frame: 1 Day
Measured as ventilations per minute.
1 Day
Tidal volume
Time Frame: 1 Day
Measured as milliliters per ventilation.
1 Day
Minute Ventilation
Time Frame: 1 Day
Measured as litres per minute.
1 Day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation of etCO2 in relation to different ratios of compression to ventilations
Time Frame: 1 Day
etCO2 measured as kilopascal for each exhalation during CPR with 30 compressions and 2 ventilations and during continous compressions and ventilations.
1 Day
Time of inspiration
Time Frame: 1 Day
Measured as seconds for each inspiration.
1 Day
Fraction of dead space ventilation
Time Frame: 1 Day
Dead space measured as milliliters for each ventilation compared to the tidal volume in milliters for that same ventilation.
1 Day
Peak inspiratory pressure during ventilation
Time Frame: 1 Day
Measured as cmH20 for each ventilation.
1 Day
Return of spontaneous circulation
Time Frame: 1 Day
If the patient, as stated by the ALS provider, has spontaneous circultation during the resuscitation attempt
1 Day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sten Rubertsson, PhD, Uppsala University department of surgical sciences
  • Study Chair: David Smekal, PhD, Uppsala University department of surgical sciences
  • Study Chair: Johan Mällberg, BsSC, Uppsala University department of surgical sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2019

Primary Completion (Actual)

August 31, 2025

Study Completion (Actual)

December 1, 2025

Study Registration Dates

First Submitted

April 4, 2019

First Submitted That Met QC Criteria

January 17, 2020

First Posted (Actual)

January 23, 2020

Study Record Updates

Last Update Posted (Actual)

April 7, 2026

Last Update Submitted That Met QC Criteria

March 31, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Out-of-Hospital Cardiac Arrest

Subscribe